The board of director of Johnson & Johnson (NYSE:JNJ) declared a dividend of USD1.06 per share on the company's common stock for the first quarter of 2022, it disclosed on Tuesday.
This cash dividend is due on 8 March 2022 to shareholders of record at the close of business as of 22 February 2022.
Johnson & Johnson added that the ex-dividend date is 18 February 2022.
According to the healthcare company, it strives to improve access and affordability, create healthier communities, put a healthy mind, body and environment within reach as well as profoundly change the trajectory of health for humanity.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva